The rising prevalence of cardiovascular diseases is expected to drive the growth of the anticoagulant market.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |